Tuesday, February 07, 2017 7:08:57 AM
Neos Therapeutics, Inc. (NASDAQ:NEOS) closed down -0.75 points or -12.93% at $5.05 with 3.73 mln shares exchanging hands. Current price level places the company’s stock about -57.02% from the 52-week high and -4.72% away from the 52-week low. Sell-side analyst recommendations point to a short term price target of $19.5 on the company shares. The consensus rating is 1.8, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $11 and a high target price of $32.
http://thewellesleysnews.com/index.php/2017/02/06/healthcare-shares-momentum-brookdale-senior-living-inc-bkd-neos-therapeutics-inc-neos/
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM